Search results
Democrats ramp up patent fight with drug industry in bid to lower prices
Washington Post· 11 hours agoPramila Jayapal (D-Wash.) this week wrote to eight pharmaceutical company CEOs, urging them to...
GSK Stock Falls as 70,000 Zantac Lawsuits Move Forward. What to Know.
InvestorPlace· 4 days agoMany investors expected today’s move in GlaxoSmithKline (NYSE:GSK), with shares of GSK stock...
GlaxoSmithKline PLC Stock Price Today | BVMF G1SK34 - Investing.com Canada
Investing.com· 4 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...
Pharma giant GSK plunges 9% after U.S. court allows scientific testimony in Zantac lawsuits
CNBC· 5 days agoCompany logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoTwo other RSV vaccines, Arexvy from GlaxoSmithKline (GSK) and Abrysvo from Pfizer, received FDA...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 4 days agoMonday saw a 9% drop in GlaxoSmithKline’s (GSK) share price on the London Stock Exchange (LSE), following a Delaware judge’s ruling on 31 May that more...
Former GSK building in Navy Yard fails to sell at sheriff's sale - Philadelphia Business Journal
The Business Journals· 2 days agoA Navy Yard office building that was formerly home to pharmaceutical giant GlaxoSmithKline failed to...
Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer
MedPage Today· 6 days agoThe antibody-drug conjugate (ADC) trastuzumab deruxtecan (T-DXd, Enhertu) significantly improved...
Nvidia dominates the AI chip market, but there's more competition than ever
CNBC· 6 days agoUnderscoring Nvidia's pricing power is a 78% gross margin, a stunningly high number for a hardware...
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 2 days agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...